COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,761 Articles (22,502 medRxiv, 8,259 bioRxiv)

Most recent first Previous |  Page 1009: Articles 10081-10090  | Next

Presentation, characteristics, treatments and outcomes of mechanically ventilated patients with COVID-19 in Bulgaria
Bakalova, N., Natsev, I., Damov, H., Yatsenko, I., Jovinska, S., Enev, R., Cholakov, M., Abedinov, F., Kalendjieva, D.
10.1101/2021.12.17.21267655 — Posted: 2021-12-17
Magnitude, global variation, and temporal development of the COVID-19 infection fatality burden
Bohk-Ewald, C., Acosta, E., Riffe, T., Dudel, C., Myrskyla, M.
10.1101/2021.12.17.21267986 — Posted: 2021-12-17
Risk of SARS-CoV-2 testing, PCR-confirmed infections and COVID-19-related hospital admissions in children and young people: birth cohort study
Hardelid, P., Favarato, G., Wijlaars, L., Fenton, L., McMenamin, J., Clemens, T., DIBBEN, C., Milojevic, A., Macfarlane, A., Taylor, J., Cunningham, S., Wood, R.
10.1101/2021.12.17.21267350 — Posted: 2021-12-17
Predictive value of isolated symptoms for diagnosis of SARS-CoV-2 infection in children tested during peak circulation of the delta variant
Westbrook, A. L., Benedit, L. C., Frediani, J. K., Griffiths, M. A., Khan, N. Y., Levy, J. M., Morris, C. R., Rostad, C. A., Stone, C. L., Sullivan, J., Vos, M. B., Welsh, J., Wood, A., Martin, G. S., Lam, W., Pollock, N. R.
10.1101/2021.12.17.21267993 — Posted: 2021-12-17
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies
VanBlargan, L. A., Errico, J. M., Halfmann, P., Zost, S. J., Crowe, J. E., Purcell, L. A., Kawaoka, Y., Corti, D., Fremont, D. H., Diamond, M.
10.1101/2021.12.15.472828 — Posted: 2021-12-17
Distinguishing COVID-19 infection and vaccination history by T cell reactivity
Yu, E. D., Wang, E., Garrigan, E., Goodwin, B., Sutherland, A., Chang, J., Galvez, R. I., Mateus, J., Rawlings, S. A., Smith, D. M., Frazier, A., Weiskopf, D., Dan, J. M., Crotty, S., Grifoni, A., Sette, A., da Silva Antunes, R.
10.1101/2021.12.15.472874 — Posted: 2021-12-17
A recurring YYDRxG pattern in broadly neutralizing antibodies to a conserved site on SARS-CoV-2, variants of concern, and related viruses
Liu, H., Kaku, C. I., Song, G., Yuan, M., Andrabi, R., Burton, D. R., Walker, L. M., Wilson, I. A.
10.1101/2021.12.15.472864 — Posted: 2021-12-17
SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2
Eales, O., Page, A., de Oliveira Martins, L., Wang, H., Bodinier, B., Haw, D., Jonnerby, J., Atchison, C., The COVID-19 Genomics UK (COG-UK) Consortium, , Ashby, D., Barclay, W., Taylor, G., Cooke, G., Ward, H., Darzi, A., Riley, S., Chadeau-Hyam, M., Donnelly, C. A., Elliott, P.
10.1101/2021.12.17.21267925 — Posted: 2021-12-17
A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients
MARQUETTE, C. H., MARTINUZZI, E., BENZAQUEN, J., GUERIN, O., LEROY, S., SIMON, T., ILIE, M., HOFMAN, V., ALLEGRA, M., TANGA, V., MICHEL, E., BOUTROS, J., MANIEL, C., SICARD, A., GLAICHENHAUS, N., CZERKINSKY, C., BLANCOU, P., HOFMAN, P.
10.1101/2021.12.16.21267932 — Posted: 2021-12-17
Patients' and carers' experiences of, and engagement with remote home monitoring services for COVID-19 patients: a rapid mixed-methods study
Walton, H., Vindrola-Padros, C., Crellin, N., Sidhu, M. S., Herlitz, L., Litchfield, I., Ellins, J., Ng, P. L., Massou, E., Tomini, S. M., Fulop, N. J.
10.1101/2021.12.17.21267968 — Posted: 2021-12-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).